A high-accuracy, low-cost blood test for Alzheimer’s disease: validating P-tau181/Aβ42 in real-world cohorts
ObjectiveTo evaluate the diagnostic performance of plasma P-tau181/Aβ42 measured via flow cytometry as a cost-effective tool for Alzheimer’s disease (AD) diagnosis.MethodsA cohort study involved 123 healthy controls, 60 AD/mild cognitive impairment (MCI) patients, 34 subcortical ischemic vascular di...
Saved in:
| Main Authors: | Dequan Liu, Hang Li, Qing Liu, Haiyan Li, Yuanyuan Tang, Kaiting Cheng, Tong Li, Yulan Chu, Xiaodong Jia, Wenying Yu, Hailan Zhou, Keqiang Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Aging Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2025.1599761/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217
by: Anna L. Wojdała, et al.
Published: (2024-12-01) -
Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
by: David Wilson, et al.
Published: (2025-07-01) -
Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
by: Corey J. Bolton, et al.
Published: (2024-10-01) -
Phospho-tau 181 is enhanced in saliva and plasma of edentulous patients: a first sign of dementia?
by: Christine Zürcher, et al.
Published: (2025-07-01) -
Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
by: Annibale Antonioni, et al.
Published: (2025-01-01)